Texas Oncology-Abilene — Abilene, Texas

Texas Oncology-Abilene is a clinical research site located in Abilene, Texas, United States 79606.

Crixeo Clinical Trials Trust Score: 20/100 (FAILING). This profile has not yet been claimed by the site owner.

Texas Oncology-Abilene has participated in 13 clinical trials with 5 currently active.

Therapeutic areas: Myelofibrosis (MF), Chronic Lymphocytic Leukemia (CLL), Ovarian Cancer.

Sponsors: AbbVie, Pharmacyclics LLC., Eli Lilly and Company.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Abilene

Browse all research sites in Texas · View every site in Abilene

• Retina Research Institute of Texas
• Hendrick Medical Center
• Texas Oncology West Texas
• Retina Res Institute of Texas
• Texas Cancer Center/Abilene
• Texas Cancer Center
• Hendrick Cancer Center
• Hendrick Health
• West Texas Retina Consultants P.A.
• Velocity Clinical Research Abilene
• Novartis Investigative Site

Sponsor Feasibility Report

Trust Score: 20/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Texas Oncology-Abilene?

Texas Oncology-Abilene has a Crixeo Trust Score of 20/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Texas Oncology-Abilene conducted?

Texas Oncology-Abilene has 13 clinical trials on record, with 5 currently active. Their work covers Myelofibrosis (MF), Chronic Lymphocytic Leukemia (CLL), Ovarian Cancer.

Is Texas Oncology-Abilene accredited by Crixeo Clinical Trials?

Texas Oncology-Abilene has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Texas Oncology-Abilene?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.